MedPath
NMPA Approval

Sodium Nitroprusside for Injection

国药准字H20093909

April 9, 2024

Drug Information

注射用硝普钠

注射剂

50mg

化学药品

April 9, 2024

Company Information

Applicant Company

广东省东莞市石龙镇西湖工业区信息产业园

Manufacturing Company

广东省东莞市石龙镇西湖工业区信息产业园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用硝普钠 - NMPA 批准文号 | MedPath